An interventional study of LigaSure Hemorrhoidectomy and Conventional Hemorrhoidectomy in LigaSure Hemorrhoidectomy, Conventional Hemorrhoidectomy and Hemorrhoids, sponsored by Sohag University. Completed at 1 site in Egypt. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-18.
Sponsored by Sohag University · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 12 studies in Hemorrhoids with a site in Egypt — 6 open to participants now, 6 under way, none of them phase 3. Hemorrhoids · Egypt.
Among the 12 studies in Hemorrhoids with a site in Egypt, this one is the 6th largest by enrollment, is one of 2 that started in 2025, is one of 12 with no phase, and was the 12th registered.
240 studies on the registry are indexed under Hemorrhoids; 73 are open to participants now.
Browse Hemorrhoids studies →6 of the 12 studies in Hemorrhoids with a site in Egypt are open now. Recruiting first, the newest first:
Sohag University · Sites in Egypt
Ages 18+
Sohag University · Sites in Egypt
Healthy volunteers
Cairo University · Sites in Egypt
Ages 18+
Ain Shams University · Sites in Egypt
Ages 18–65 · Healthy volunteers
Mansoura University · Sites in Egypt
Ages 18–65
A study can be open while its sites in Egypt have not opened yet or have stopped. Only those recruiting at a site in Egypt →
Of the 38 Hemorrhoids studies recruiting now, 15 (39%) set no upper age limit and 11 (29%) stop at 75 or younger; 2 take children under 18; 4 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
12 studies; the count open now beside each. This study's row is marked.
First in 2017; this study’s year is marked. 2 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 90 is close to the median of 100 across 185 interventional studies indexed under Hemorrhoids.
Median enrollment 90 across the 12 interventional studies. Of the 5 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 12 has an industry lead sponsor. The 7 most frequent:
Sohag University is the lead sponsor of 1,235 studies on the registry; 639 are open to participants now.
Sohag University has 3 studies filed under Hemorrhoids — fewer than ten, so there is no comparison to draw.
4 of the studies in Hemorrhoids with a site in Egypt that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07598630Cairo UniversitySHAPE Versus Milligan-Morgan Hemorrhoidectomy for Hemorrhoidal Disease | 2027-01-01 |
| NCT07878546Sohag UniversityLigasure Versus Conventional Diathermy in Hemorrhoidectomy | 2027-03-26 |
| NCT07824999Sohag UniversitySutureless Hemorrhoidectomy Versus Conventional Ligation in Advanced Hemorrhoids | 2027-04-01 |
| NCT07714122Cairo UniversityCryotherapy for Post-Hemorrhoidectomy Pain | 2027-06 |
Add all 4 to your calendar (.ics) → With an account.
Among the 12 studies in Hemorrhoids with a site in Egypt, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This study aimed to compare the short-term outcomes of LigaSure hemorrhoidectomy and conventional diathermy hemorrhoidectomy.
Hemorrhoidal disease affects about 5% of the general population. Excisional hemorrhoidectomy remains the definitive treatment for individuals with grade III and IV hemorrhoids.
Several clinical trials have assessed LigaSure hemorrhoidectomy [LH] with conventional excisional techniques. A pooled analysis of previous trials described better short-term results with LH, including shorter operating time, less intraoperative blood loss, less pain after surgery scores, an earlier return to normal activity, and faster wound healing.
Despite these encouraging results, delayed postoperative bleeding after LH still warrants attention. One comparison of LH with Ferguson [closed] hemorrhoidectomy found similar rates in postoperative bleeding between the two techniques.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Participants underwent excisional hemorrhoidectomy with the LigaSure vessel sealing system.
Procedure: LigaSure Hemorrhoidectomy
Participants underwent conventional open diathermy hemorrhoidectomy with the Milligan-Morgan technique.
Procedure: Conventional Hemorrhoidectomy
Participants underwent excisional hemorrhoidectomy with the LigaSure vessel sealing system.
Participants underwent conventional open diathermy hemorrhoidectomy with the Milligan-Morgan technique.
Degree of pain
Postoperative pain intensity was assessed using the visual analog scale (VAS). VAS range from 0 (no pain) to 10 (worst imaginable pain).
Time frame: 24 hours after surgery
Operative duration
Operative duration was recorded from the start of surgery till the end of surgery.
Time frame: Till the end of surgery (Up to 2 hours)
Length of Hospital Stay
Length of Hospital Stay was recorded from the admission till the discharge from hospital.
Time frame: Till the discharge from hospital (Up to 2 weeks)
Time to Return to Work
Number of days from surgery until the participant resumes work.
Time frame: 6 months postoperatively
Incidence of postoperative complications
Incidence of postoperative complications were recorded.
Time frame: 6 months postoperatively
Degree of patient satisfaction
Degree of patient satisfaction was assessed on a 5-point Likert scale patient satisfaction (1, extremely dissatisfied; 2, unsatisfied; 3, neutral; 4, satisfied; 5, extremely satisfied)
Time frame: 24 hours after surgery
Plan to share: Yes — The data will be available upon a reasonable request from the corresponding author after the end of study for one year.
Supporting information: Study protocol
Time frame: After the end of study for one year.
Access criteria: The data will be available upon a reasonable request from the corresponding author.
No publications or documents are linked to this record.
Ran from May 2025 to primary completion in Apr 2026, 11 months.
Of 67 non-industry interventional studies with no phase under Hemorrhoids, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 35. This study's 11 months is below that.
Counting every sponsor, half of 72 studies reached it within 20 months; a quarter within 10 and three quarters within 35.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.